Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rollover Study of Parsaclisib in B-Cell Malignancies
NCT04509700Phase 2Active, not recruiting
- Sponsor
- Incyte
- Start
- Aug 2020
- Primary completion
- Nov 2026
- Modality
- Small Molecules
- Countries
- 17
01
Overview
A Phase 2 trial of parsaclisib in B cell malignancies, sponsored by Incyte. Started Aug 2020; status: active, not recruiting.
02
Drugs
parsaclisib
03
Conditions
B cell malignancies
Beyond the preview
Go deeper on NCT04509700.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04509700.